Fortress Biotech Q3 EPS $0.11 Beats $(0.42) Estimate, Sales $17.631M Miss $21.018M Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsEarnings MissesNews
Fortress Biotech (NASDAQ:FBIO) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.42) by 126.19 percent. This is a 114.47 percent increase over losses of $(0.76) per share
Fortress Biotech (NASDAQ:FBIO) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.42) by 126.19 percent. This is a 114.47 percent increase over losses of $(0.76) per share from the same period last year. The company reported quarterly sales of $17.631 million which missed the analyst consensus estimate of $21.018 million by 16.12 percent. This is a 20.52 percent increase over sales of $14.629 million the same period last year.